SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016490
Filing Date
2018-11-19
Accepted
2018-11-19 16:39:54
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 765618
2 ex31-1.htm EX-31.1 9908
3 ex31-2.htm EX-31.2 19005
4 ex32-1.htm EX-32.1 4164
5 ex32-2.htm EX-32.2 4251
  Complete submission text file 0001493152-18-016490.txt   4047491

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atrx-20180930.xml EX-101.INS 548911
7 XBRL SCHEMA FILE atrx-20180930.xsd EX-101.SCH 47820
8 XBRL CALCULATION FILE atrx-20180930_cal.xml EX-101.CAL 48849
9 XBRL DEFINITION FILE atrx-20180930_def.xml EX-101.DEF 244173
10 XBRL LABEL FILE atrx-20180930_lab.xml EX-101.LAB 355652
11 XBRL PRESENTATION FILE atrx-20180930_pre.xml EX-101.PRE 296778
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 181192958
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1